CARE
رعايةTechnical Analysis & Signals
Riyadah stock (4005.SR) is experiencing a strong downtrend with negative signals in technical analysis.
Technical Analysis
The stock is in a clear downtrend, with the Relative Strength Index (RSI) showing a low level of 28.6, indicating oversold conditions. Additionally, the negative MACD Histogram crossover reinforces the likelihood of the downtrend continuing.
Support & Resistance Levels
The main support level is at 100.7 SAR, while the resistance level is at 117.93 SAR. The stock is expected to struggle to break through the resistance level given the current downtrend.
Volume Analysis
Trading volume may indicate a decline in activity, reflecting weak demand for the stock. This could lead to further selling pressure in the near future.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 14.5 with a dividend yield of 2.88%, indicating reasonable valuation. However, the weak market performance may negatively impact investor confidence in the stock.
Risk Factors
Risks include the continuation of the downtrend, which could lead to further losses. Additionally, the overall economic conditions in the Saudi market may impact the stock's performance.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to monitor support and resistance levels and make decisions based on comprehensive analysis.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - CARE
4005Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 4.62B
- P/E Ratio
- 14.50
- P/B Ratio
- 2.50
- EPS (Earnings/Share)
- 7.13
Profitability
- Revenue
- 1.60B
- Net Income
- 318.47M
- Return on Equity (ROE)
- +20.00%
- Shares Outstanding
- 44.69M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 516.03M
- Debt/Equity
- 0.28
- Free Float %
- +50.6%
Dividends & Margins
- Dividend Yield
- +2.88%
- Dividend/Share
- 3.00
- Book Value
- 41.32
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
5 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2025 | 1.60B +23.7% | 318.47M +8.1% | 2.77B +10.9% | 516.03M +5.8% | 7.13 +8.2% |
| 2024 | 1.29B +19.6% | 294.70M +22.3% | 2.50B +12.8% | 487.73M +47.7% | 6.59 +22.3% |
| 2023 | 1.08B +17.8% | 240.93M +41.7% | 2.21B +29.3% | 330.25M +297.0% | 5.39 +41.5% |
| 2022 | 917.93M | 170.07M | 1.71B | 83.19M | 3.81 |
| 2021 | — | — | — | — | — |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Care CEO says higher Q4 2025 topline fueled by patient visits
United Securities identifies 7 top Saudi picks for 2026
Care signs SAR 392M contract for MEP works at Al Narjis hospital
Care secures SAR 228.5M Murabaha financing from SAB
ANB Capital reviews Q4 2025 financials of four healthcare firms
AlJazira Capital issues Q4 2025 profit forecasts
Care plans capacity expansion, fresh strategy
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 224.60 SAR | |
| 4002 | Mouwasat | 66.50 SAR | |
| 4004 | Dallah Healthcare | 112.00 SAR | |
| 4017 | Fakeeh Care | 36.00 SAR | |
| 4018 | Almoosa | 129.50 SAR | |
| 4005 | CARE | 103.30 SAR | |
| 4019 | SMC Healthcare | 17.60 SAR | |
| 4007 | Alhammadi | 25.32 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-05-11
Risk Assessment
Risk Factors
Average True Range 5.7% of stock price
Trading volume near or above average
P/E ratio 14.5 — below average
Debt-to-equity ratio 0.28
ADX indicator at 28
Very high volatility or severe financial pressures requiring extreme caution
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is CARE stock price today?
CARE (4005) stock price today is 103.30 SAR, declining by -0.77% compared to the previous session close. The 52-week price range is between 100.70 SAR and 178.92 SAR.
2 What is CARE stock valuation?
The automated analysis signal for CARE is "Strong Sell" with 85% confidence. The P/E ratio is 14.5. The P/B ratio is 2.50.
3 Is CARE Shariah-compliant?
Yes, CARE (4005) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are CARE dividend distributions?
CARE has a dividend yield of 2.88%, with an estimated annual dividend of 3.00 SAR per share.
5 What is CARE weekly performance?
CARE performance over different time periods: weekly change -11.94%, monthly -20.16%, and year-to-date -25.97%. The stock is currently trading with a volume of 324,081 shares.
6 What is the target level for CARE?
According to automated analysis for CARE: Short-term target (1-2 weeks): 100.00 SAR. Support level: 100.70 SAR. Resistance level: 117.93 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.